DCVax-L
merck,northwest biotherapeutics
['solid tumor', 'keytruda', 'nwbo']
 annually keytruda serves 0.6% of global newly diagnosed cancer patients. number one drug sold today. so there's a huge number of patients not being helped by current type of oncology treatments available. don't work. too expensive. $nwbo dcvax all solid tumors! #asco22
Sharing knowledge about #DCVax.  Long $NWBO.

Not investment advice.

Do your own research. 

https://t.co/Vy854YELlC